Akoya Perspectives Archives

We’ve rebranded some of our products, learn more ›

CODEX® is now PhenoCycler,
Phenoptics™ is now Phenolmager.

Category: Akoya Perspectives

Can proteomics help improve phase II trial success rates? Q&A with a precision oncology pioneer

Collection: Akoya Perspectives
Tags: Cancer, Immuno-Oncology

How can we help progress promising cancer therapies to the clinic? Proteomics based companion diagnostic (CDx) tests are emerging as a critical success factor. Read more to learn how Acrivon Therapeutics and Akoya’s technologies are paving the way forward.

Collaborating with Agilent to Catalyze Precision Medicine

Collection: Akoya Perspectives
Tags: Cancer, Immuno-Oncology, Immunotherapy, Spatial Analysis

Learn about our recent partnership with Agilent to drive multiplex tissue assay development for biopharma applications and find out why spatial signatures represent a paradigm shift in immunotherapy predicitive biomarkers.

Keeping Pace with the Ever-changing Combination Therapy Landscape

Collection: Akoya Perspectives
Tags: Immuno-Oncology, Spatial Analysis

There are more than 100 chemotherapy drugs available today with a regular cadence of new drugs being introduced each year. It’s fair to say that there is no such thing as “one size fits all” approach when it comes to dealing with cancer. There are endless individual and…

The PhenoTalk Ep. 1: Dr. Subham Basu and Dr. Oliver Braubach

Collection: Akoya Perspectives
Tags: Immuno-Oncology, Spatial Analysis

In our inaugural episode of The PhenoTalk we sit down with Dr. Oliver Braubach and Dr. Subham Basu.

What it Takes to Create an Organ Atlas – The Road Trip of a Lifetime

Collection: Akoya Perspectives
Tags: Spatial Analysis

Building an organ atlas is an important but very difficult job. Organ atlases aim to catalog all the cell types and subtypes throughout the human body while also mapping their location, architecture, and function…

Tertiary Lymphoid Structures – A Promising Biomarker for Immunotherapy

Collection: Akoya Perspectives
Tags: Immuno-Oncology

Tertiary lymphoid structures (TLS) have been a hot topic in the field of immuno-oncology, where it is believed they play a critical important role in influencing the tumor microenvironment. Commonly seen in invasive carcinoma, their presence is associated with improvement in clinical outcomes…

Pushing Innovation: From What If to What else…

Collection: Akoya Perspectives
Tags: Immuno-Oncology, Spatial Analysis

As the capabilities of spatial biology evolve so to must the questions, we ask ourselves as researchers. The field of spatial biology has seen rapid developments in theoretical frameworks and instrumentation, all of which revealing a clear path towards the innovation of novel perspectives allowing us to…

10 Reasons We Are Excited About PhenoCycler-Fusion

Collection: Akoya Perspectives
Tags: Cancer, Immuno-Oncology

Spatial phenotyping is the power to visualize and quantify dozens of biomarkers in a single tissue sample while maintaining cellular and sub-cellular detail. Comprehensive spatial phenotyping can reveal cell diversity, co-expression patterns, cellular interactions, broader tissue architecture, and…

Introducing PhenoCycler-Fusion: Setting the Pace in Spatial Biology

Collection: Akoya Perspectives

Keeping pace in the rapidly growing field of spatial biology is a steep hill to climb—every day new applications are being discovered and our capabilities for deep investigation grow deeper. Setting the pace is an even tougher challenge, but difficult as it…

Our Rebranded Product Portfolio:
New Names, Same Powerful Technology

Collection: Akoya Perspectives

These are exciting times at Akoya Biosciences, and we have some important news to share with you. We are renaming some of our products and we’d like to share the reasons with you. But rest assured, our core products and how you order them will not change…

Stay Connected

"*" indicates required fields

Terms and Conditions Privacy Policy

CODEX® is now PhenoCycler,
Phenoptics™ is now Phenolmager.

Category: Akoya Perspectives

Can proteomics help improve phase II trial success rates? Q&A with a precision oncology pioneer

Collaborating with Agilent to Catalyze Precision Medicine

Keeping Pace with the Ever-changing Combination Therapy Landscape

The PhenoTalk Ep. 1: Dr. Subham Basu and Dr. Oliver Braubach

What it Takes to Create an Organ Atlas – The Road Trip of a Lifetime

Tertiary Lymphoid Structures – A Promising Biomarker for Immunotherapy

Pushing Innovation: From What If to What else…

10 Reasons We Are Excited About PhenoCycler-Fusion

Introducing PhenoCycler-Fusion: Setting the Pace in Spatial Biology

Our Rebranded Product Portfolio:
New Names, Same Powerful Technology

Follow Us

More Links

Stay Connected

CODEX® is now PhenoCycler, Phenoptics™ is now Phenolmager.

Category: Akoya Perspectives

Follow Us

More Links

Stay Connected

CODEX® is now PhenoCycler,
Phenoptics™ is now Phenolmager.